{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T06:07:11Z","timestamp":1782799631210,"version":"3.54.5"},"reference-count":62,"publisher":"Walter de Gruyter GmbH","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,5,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>At the end of 19th century, Adolf von Str\u00fcmpell and Sigmund Freud independently described the symptoms of a new pathology now known as hereditary spastic paraplegia (HSP). HSP is part of the group of genetic neurodegenerative diseases usually associated with slow progressive pyramidal syndrome, spasticity, weakness of the lower limbs, and distal-end degeneration of motor neuron long axons. Patients are typically characterized by gait symptoms (with or without other neurological disorders), which can appear both in young and adult ages depending on the different HSP forms. The disease prevalence is at 1.3\u20139.6 in 100 000 individuals in different areas of the world, making HSP part of the group of rare neurodegenerative diseases. Thus far, there are no specific clinical and paraclinical tests, and DNA analysis is still the only strategy to obtain a certain diagnosis. For these reasons, it is mandatory to extend the knowledge on genetic causes, pathology mechanism, and disease progression to give clinicians more tools to obtain early diagnosis, better therapeutic strategies, and examination tests. This review gives an overview of HSP pathologies and general insights to a specific HSP subtype called spastic paraplegia 31 (SPG31), which rises after mutation of <jats:italic>REEP1<\/jats:italic> gene. In fact, recent findings discovered an interesting endoplasmic reticulum antistress function of REEP1 and a role of this protein in preventing \u03c4 accumulation in animal models. For this reason, this work tries to elucidate the main aspects of REEP1, which are described in the literature, to better understand its role in SPG31 HSP and other pathologies.<\/jats:p>","DOI":"10.1515\/revneuro-2019-0083","type":"journal-article","created":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T09:07:35Z","timestamp":1578474455000},"page":"351-362","source":"Crossref","is-referenced-by-count":11,"title":["A complete overview of REEP1: old and new insights on its role in hereditary spastic paraplegia and neurodegeneration"],"prefix":"10.1515","volume":"31","author":[{"given":"Alessio","family":"Guglielmi","sequence":"first","affiliation":[{"name":"Neurobiology Laboratory , International Centre of Genetic Engineering and Biotechnology , I-34149 Trieste , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2020,1,8]]},"reference":[{"key":"2022062616291799384_j_revneuro-2019-0083_ref_001_w2aab3b7b7b1b6b1ab2ab1Aa","doi-asserted-by":"crossref","unstructured":"Allison, R., Edgar, J.R., Pearson, G., Rizo, T., Newton, T., G\u00fcnther, S., Berner, F., Hague, J., Connell, J.W., Winkler, J., et al. (2017). Defects in ER-endosome contacts impact lysosome function in hereditary spastic paraplegia. J. Cell Biol. 216, 1337\u20131355.","DOI":"10.1083\/jcb.201609033"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_002_w2aab3b7b7b1b6b1ab2ab2Aa","doi-asserted-by":"crossref","unstructured":"Appocher, C., Klima, R., and Feiguin, F. (2014). Functional screening in Drosophila reveals the conserved role of REEP1 in promoting stress resistance and preventing the formation of \u03c4 aggregates. Hum. Mol. Genet. 23, 6762\u20136772.","DOI":"10.1093\/hmg\/ddu393"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_003_w2aab3b7b7b1b6b1ab2ab3Aa","doi-asserted-by":"crossref","unstructured":"Beetz, C., Sch\u00fcle, R., Deconinck, T., Tran-Viet, K.-N., Zhu, H., Kremer, B.P.H., Frints, S.G.M., van Zelst-Stams, W.A.G., Byrne, P., Otto, S., et al. (2008). REEP1 mutation spectrum and genotype\/phenotype correlation in hereditary spastic paraplegia type 31. Brain J. Neurol. 131, 1078\u20131086.","DOI":"10.1093\/brain\/awn026"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_004_w2aab3b7b7b1b6b1ab2ab4Aa","doi-asserted-by":"crossref","unstructured":"Beetz, C., Pieber, T.R., Hertel, N., Schabh\u00fcttl, M., Fischer, C., Trajanoski, S., Graf, E., Keiner, S., Kurth, I., Wieland, T., et al. (2012). Exome sequencing identifies a REEP1 mutation involved in distal hereditary motor neuropathy type V. Am. J. Hum. Genet. 91, 139\u2013145.","DOI":"10.1016\/j.ajhg.2012.05.007"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_005_w2aab3b7b7b1b6b1ab2ab5Aa","doi-asserted-by":"crossref","unstructured":"Beetz, C., Koch, N., Khundadze, M., Zimmer, G., Nietzsche, S.,Hertel, N., Huebner, A.-K., Mumtaz, R., Schweizer, M., Dirren, E., et al. (2013). A spastic paraplegia mouse model reveals REEP1-dependent ER shaping. J. Clin. Invest. 123, 4273\u20134282.","DOI":"10.1172\/JCI65665"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_006_w2aab3b7b7b1b6b1ab2ab6Aa","doi-asserted-by":"crossref","unstructured":"Behan, W.M. and Maia, M. (1974). Str\u00fcmpell\u2019s familial spastic paraplegia: genetics and neuropathology. J. Neurol. Neurosurg. Psychiatry 37, 8\u201320.","DOI":"10.1136\/jnnp.37.1.8"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_007_w2aab3b7b7b1b6b1ab2ab7Aa","doi-asserted-by":"crossref","unstructured":"Behrens, M., Bartelt, J., Reichling, C., Winnig, M., Kuhn, C., and Meyerhof, W. (2006). Members of RTP and REEP gene families influence functional bitter taste receptor expression. J. Biol. Chem. 281, 20650\u201320659.","DOI":"10.1074\/jbc.M513637200"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_008_w2aab3b7b7b1b6b1ab2ab8Aa","doi-asserted-by":"crossref","unstructured":"B\u00e9reau, M., Anheim, M., Chanson, J.-B., Tio, G., Echaniz-Laguna, A., Depienne, C., Collongues, N., and de S\u00e8ze, J. (2015). Dalfampridine in hereditary spastic paraplegia: a prospective, open study. J. Neurol. 262, 1285\u20131288.","DOI":"10.1007\/s00415-015-7707-6"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_009_w2aab3b7b7b1b6b1ab2ab9Aa","doi-asserted-by":"crossref","unstructured":"Bertolucci, F., Di Martino, S., Orsucci, D., Ienco, E.C., Siciliano, G., Rossi, B., Mancuso, M., and Chisari, C. (2015). Robotic gait training improves motor skills and quality of life in hereditary spastic paraplegia. Neurorehabilitation 36, 93\u201399.","DOI":"10.3233\/NRE-141196"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_010_w2aab3b7b7b1b6b1ab2ac10Aa","doi-asserted-by":"crossref","unstructured":"Bj\u00f6rk, S., Hurt, C.M., Ho, V.K., and Angelotti, T. (2013). REEPs are membrane shaping adapter proteins that modulate specific G protein-coupled receptor trafficking by affecting ER cargo capacity. PLoS One 8, e76366.","DOI":"10.1371\/journal.pone.0076366"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_011_w2aab3b7b7b1b6b1ab2ac11Aa","doi-asserted-by":"crossref","unstructured":"Charvin, D., Cifuentes-Diaz, C., Fonknechten, N., Joshi, V., Hazan, J., Melki, J., and Betuing, S. (2003). Mutations of SPG4 are responsible for a loss of function of spastin, an abundant neuronal protein localized in the nucleus. Hum. Mol. Genet. 12, 71\u201378.","DOI":"10.1093\/hmg\/ddg004"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_012_w2aab3b7b7b1b6b1ab2ac12Aa","doi-asserted-by":"crossref","unstructured":"Eastman, S.W., Yassaee, M., and Bieniasz, P.D. (2009). A role for ubiquitin ligases and Spartin\/SPG20 in lipid droplet turnover. J. Cell Biol. 184, 881\u2013894.","DOI":"10.1083\/jcb.200808041"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_013_w2aab3b7b7b1b6b1ab2ac13Aa","doi-asserted-by":"crossref","unstructured":"Edwards, T.L., Clowes, V.E., Tsang, H.T.H., Connell, J.W., Sanderson, C.M., Luzio, J.P., and Reid, E. (2009). Endogenous spartin (SPG20) is recruited to endosomes and lipid droplets and interacts with the ubiquitin E3 ligases AIP4 and AIP5. Biochem. J. 423, 31\u201339.","DOI":"10.1042\/BJ20082398"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_014_w2aab3b7b7b1b6b1ab2ac14Aa","doi-asserted-by":"crossref","unstructured":"Errico, A., Ballabio, A., and Rugarli, E.I. (2002). Spastin, the protein mutated in autosomal dominant hereditary spastic paraplegia, is involved in microtubule dynamics. Hum. Mol. Genet. 11, 153\u2013163.","DOI":"10.1093\/hmg\/11.2.153"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_015_w2aab3b7b7b1b6b1ab2ac15Aa","doi-asserted-by":"crossref","unstructured":"Falk, J., Rohde, M., Bekhite, M.M., Neugebauer, S., Hemmerich, P., Kiehntopf, M., Deufel, T., H\u00fcbner, C.A., and Beetz, C. (2014). Functional mutation analysis provides evidence for a role of REEP1 in lipid droplet biology. Hum. Mutat. 35, 497\u2013504.","DOI":"10.1002\/humu.22521"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_016_w2aab3b7b7b1b6b1ab2ac16Aa","doi-asserted-by":"crossref","unstructured":"Fink, J.K. (2003). Advances in the hereditary spastic paraplegias. Exp. Neurol. 184, S106\u2013S110.","DOI":"10.1016\/j.expneurol.2003.08.005"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_017_w2aab3b7b7b1b6b1ab2ac17Aa","doi-asserted-by":"crossref","unstructured":"Fink, J.K. (2013). Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms. Acta Neuropathol. (Berl.) 126, 307\u2013328.","DOI":"10.1007\/s00401-013-1115-8"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_018_w2aab3b7b7b1b6b1ab2ac18Aa","doi-asserted-by":"crossref","unstructured":"Finsterer, J., L\u00f6scher, W., Quasthoff, S., Wanschitz, J., Auer-Grumbach, M., and Stevanin, G. (2012). Hereditary spastic paraplegias with autosomal dominant, recessive, X-linked, or maternal trait of inheritance. J. Neurol. Sci. 318, 1\u201318.","DOI":"10.1016\/j.jns.2012.03.025"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_019_w2aab3b7b7b1b6b1ab2ac19Aa","doi-asserted-by":"crossref","unstructured":"Fontaine, B., Davoine, C.S., D\u00fcrr, A., Paternotte, C., Feki, I., Weissenbach, J., Hazan, J., and Brice, A. (2000). A new locus for autosomal dominant pure spastic paraplegia, on chromosome 2q24-q34. Am. J. Hum. Genet. 66, 702\u2013707.","DOI":"10.1086\/302776"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_020_w2aab3b7b7b1b6b1ab2ac20Aa","doi-asserted-by":"crossref","unstructured":"Goizet, C., Depienne, C., Benard, G., Boukhris, A., Mundwiller, E., Sol\u00e9, G., Coupry, I., Pilliod, J., Martin-N\u00e9grier, M.-L., Fedirko, E., et al. (2011). REEP1 mutations in SPG31: frequency, mutational spectrum, and potential association with mitochondrial morpho-functional dysfunction. Hum. Mutat. 32, 1118\u20131127.","DOI":"10.1002\/humu.21542"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_021_w2aab3b7b7b1b6b1ab2ac21Aa","doi-asserted-by":"crossref","unstructured":"Harding, A.E. (1993). Hereditary spastic paraplegias. Semin. Neurol. 13, 333\u2013336.","DOI":"10.1055\/s-2008-1041143"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_022_w2aab3b7b7b1b6b1ab2ac22Aa","doi-asserted-by":"crossref","unstructured":"Hashimoto, Y., Shirane, M., Matsuzaki, F., Saita, S., Ohnishi, T., and Nakayama, K.I. (2014). Protrudin regulates endoplasmic reticulum morphology and function associated with the pathogenesis of hereditary spastic paraplegia. J. Biol. Chem. 289, 12946\u201312961.","DOI":"10.1074\/jbc.M113.528687"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_023_w2aab3b7b7b1b6b1ab2ac23Aa","doi-asserted-by":"crossref","unstructured":"Hewamadduma, C., McDermott, C., Kirby, J., Grierson, A., Panayi, M., Dalton, A., Rajabally, Y., and Shaw, P. (2009). New pedigrees and novel mutation expand the phenotype of REEP1-associated hereditary spastic paraplegia (HSP). Neurogenetics 10, 105\u2013110.","DOI":"10.1007\/s10048-008-0163-z"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_024_w2aab3b7b7b1b6b1ab2ac24Aa","doi-asserted-by":"crossref","unstructured":"Hooper, C., Puttamadappa, S.S., Loring, Z., Shekhtman, A., and Bakowska, J.C. (2010). Spartin activates atrophin-1-interacting protein 4 (AIP4) E3 ubiquitin ligase and promotes ubiquitination of adipophilin on lipid droplets. BMC Biol. 8, 72.","DOI":"10.1186\/1741-7007-8-72"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_025_w2aab3b7b7b1b6b1ab2ac25Aa","doi-asserted-by":"crossref","unstructured":"Hurt, C.M., Bj\u00f6rk, S., Ho, V.K., Gilsbach, R., Hein, L., and Angelotti, T. (2014). REEP1 and REEP2 proteins are preferentially expressed in neuronal and neuronal-like exocytotic tissues. Brain Res. 1545, 12\u201322.","DOI":"10.1016\/j.brainres.2013.12.008"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_026_w2aab3b7b7b1b6b1ab2ac26Aa","doi-asserted-by":"crossref","unstructured":"Jia, X., Madireddy, L., Caillier, S., Santaniello, A., Esposito, F., Comi, G., Stuve, O., Zhou, Y., Taylor, B., Kilpatrick, T., et al. (2018). Genome sequencing uncovers phenocopies in primary progressive multiple sclerosis. Ann. Neurol. 84, 51\u201363.","DOI":"10.1002\/ana.25263"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_027_w2aab3b7b7b1b6b1ab2ac27Aa","doi-asserted-by":"crossref","unstructured":"Kenwrick, S., Watkins, A., and De Angelis, E. (2000). Neural cell recognition molecule L1: relating biological complexity to human disease mutations. Hum. Mol. Genet. 9, 879\u2013886.","DOI":"10.1093\/hmg\/9.6.879"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_028_w2aab3b7b7b1b6b1ab2ac28Aa","doi-asserted-by":"crossref","unstructured":"Lavie, J., Serrat, R., Bellance, N., Courtand, G., Dupuy, J.-W., Tesson, C., Coupry, I., Brice, A., Lacombe, D., Durr, A., et al. (2017). Mitochondrial morphology and cellular distribution are altered in SPG31 patients and are linked to DRP1 hyperphosphorylation. Hum. Mol. Genet. 26, 674\u2013685.","DOI":"10.1093\/hmg\/ddw425"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_029_w2aab3b7b7b1b6b1ab2ac29Aa","doi-asserted-by":"crossref","unstructured":"Lim, Y., Cho, I.-T., Schoel, L.J., Cho, G., and Golden, J.A. (2015). Hereditary spastic paraplegia-linked REEP1 modulates endoplasmic reticulum\/mitochondria contacts. Ann. Neurol. 78, 679\u2013696.","DOI":"10.1002\/ana.24488"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_030_w2aab3b7b7b1b6b1ab2ac30Aa","doi-asserted-by":"crossref","unstructured":"Liu, S.G., Che, F.Y., Heng, X.Y., Li, F.F., Huang, S.Z., Lu, D.G., Hou, S.J., Liu, S.E., Wang, Q., Wang, H.P., et al. (2009). Clinical and genetic study of a novel mutation in the REEP1 gene. Synapse 63, 201\u2013205.","DOI":"10.1002\/syn.20602"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_031_w2aab3b7b7b1b6b1ab2ac31Aa","doi-asserted-by":"crossref","unstructured":"McCorquodale, D.S., Ozomaro, U., Huang, J., Montenegro, G., Kushman, A., Citrigno, L., Price, J., Speziani, F., Pericak-Vance, M.A., and Z\u00fcchner, S. (2011). Mutation screening of spastin, atlastin, and REEP1 in hereditary spastic paraplegia. Clin. Genet. 79, 523\u2013530.","DOI":"10.1111\/j.1399-0004.2010.01501.x"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_032_w2aab3b7b7b1b6b1ab2ac32Aa","doi-asserted-by":"crossref","unstructured":"McDermott, C., White, K., Bushby, K., and Shaw, P. (2000). Hereditary spastic paraparesis: a review of new developments. J. Neurol. Neurosurg. Psychiatry 69, 150\u2013160.","DOI":"10.1136\/jnnp.69.2.150"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_033_w2aab3b7b7b1b6b1ab2ac33Aa","doi-asserted-by":"crossref","unstructured":"McMonagle, P., Webb, S., and Hutchinson, M. (2002). The prevalence of \u201cpure\u201d autosomal dominant hereditary spastic paraparesis in the island of Ireland. J. Neurol. Neurosurg. Psychiatry 72, 43\u201346.","DOI":"10.1136\/jnnp.72.1.43"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_034_w2aab3b7b7b1b6b1ab2ac34Aa","doi-asserted-by":"crossref","unstructured":"Miura, S., Shibata, H., Kida, H., Noda, K., Tomiyasu, K., Yamamoto, K., Iwaki, A., Ayabe, M., Aizawa, H., Taniwaki, T., et al. (2008). Hereditary motor and sensory neuropathy with proximal dominancy in the lower extremities, urinary disturbance, and paroxysmal dry cough. J. Neurol. Sci. 273, 88\u201392.","DOI":"10.1016\/j.jns.2008.06.027"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_035_w2aab3b7b7b1b6b1ab2ac35Aa","doi-asserted-by":"crossref","unstructured":"Mondrup, K. and Pedersen, E. (1984). The clinical effect of the GABA-agonist, progabide, on spasticity. Acta Neurol. Scand. 69, 200\u2013206.","DOI":"10.1111\/j.1600-0404.1984.tb07802.x"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_036_w2aab3b7b7b1b6b1ab2ac36Aa","doi-asserted-by":"crossref","unstructured":"Park, S.H., Zhu, P.-P., Parker, R.L., and Blackstone, C. (2010). Hereditary spastic paraplegia proteins REEP1, spastin, and atlastin-1 coordinate microtubule interactions with the tubular ER network. J. Clin. Invest. 120, 1097\u20131110.","DOI":"10.1172\/JCI40979"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_037_w2aab3b7b7b1b6b1ab2ac37Aa","doi-asserted-by":"crossref","unstructured":"Pease, W.S. (1998). Therapeutic electrical stimulation for spasticity: quantitative gait analysis. Am. J. Phys. Med. Rehabil. 77, 351\u2013355.","DOI":"10.1097\/00002060-199807000-00021"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_038_w2aab3b7b7b1b6b1ab2ac38Aa","doi-asserted-by":"crossref","unstructured":"Reid, E., Kloos, M., Ashley-Koch, A., Hughes, L., Bevan, S., Svenson, I.K., Graham, F.L., Gaskell, P.C., Dearlove, A., Pericak-Vance, M.A., et al. (2002). A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10). Am. J. Hum. Genet. 71, 1189\u20131194.","DOI":"10.1086\/344210"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_039_w2aab3b7b7b1b6b1ab2ac39Aa","doi-asserted-by":"crossref","unstructured":"Renvois\u00e9, B., Malone, B., Falgairolle, M., Munasinghe, J., Stadler, J., Sibilla, C., Park, S.H., and Blackstone, C. (2016). Reep1 null mice reveal a converging role for hereditary spastic paraplegia proteins in lipid droplet regulation. Hum. Mol. Genet. 25, 5111\u20135125.","DOI":"10.1093\/hmg\/ddw315"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_040_w2aab3b7b7b1b6b1ab2ac40Aa","doi-asserted-by":"crossref","unstructured":"Richard, S., Lavie, J., Banneau, G., Voirand, N., Lavandier, K., and Debouverie, M. (2017). Hereditary spastic paraplegia due to a novel mutation of the REEP1 gene: case report and literature review. Medicine (Baltimore) 96, e5911.","DOI":"10.1097\/MD.0000000000005911"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_041_w2aab3b7b7b1b6b1ab2ac41Aa","doi-asserted-by":"crossref","unstructured":"Saito, H., Kubota, M., Roberts, R.W., Chi, Q., and Matsunami, H. (2004). RTP family members induce functional expression of mammalian odorant receptors. Cell 119, 679\u2013691.","DOI":"10.1016\/j.cell.2004.11.021"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_042_w2aab3b7b7b1b6b1ab2ac42Aa","doi-asserted-by":"crossref","unstructured":"Schlang, K.J., Arning, L., Epplen, J.T., and Stemmler, S. (2008). Autosomal dominant hereditary spastic paraplegia: novel mutations in the REEP1 gene (SPG31). BMC Med. Genet. 9, 71.","DOI":"10.1186\/1471-2350-9-71"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_043_w2aab3b7b7b1b6b1ab2ac43Aa","doi-asserted-by":"crossref","unstructured":"Schottmann, G., Seelow, D., Seifert, F., Morales-Gonzalez, S., Gill, E., von Au, K., von Moers, A., Stenzel, W., and Schuelke, M. (2015). Recessive REEP1 mutation is associated with congenital axonal neuropathy and diaphragmatic palsy. Neurol. Genet. 1, e32.","DOI":"10.1212\/NXG.0000000000000032"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_044_w2aab3b7b7b1b6b1ab2ac44Aa","doi-asserted-by":"crossref","unstructured":"Schwarz, G.A. and Liu, C.N. (1956). Hereditary (familial) spastic paraplegia; further clinical and pathologic observations. AMA Arch. Neurol. Psychiatry 75, 144\u2013162.","DOI":"10.1001\/archneurpsyc.1956.02330200038005"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_045_w2aab3b7b7b1b6b1ab2ac45Aa","doi-asserted-by":"crossref","unstructured":"Sedel, F., Fontaine, B., Saudubray, J.M., and Lyon-Caen, O. (2007). Hereditary spastic paraparesis in adults associated with inborn errors of metabolism: a diagnostic approach. J. Inherit. Metab. Dis. 30, 855\u2013864.","DOI":"10.1007\/s10545-007-0745-1"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_046_w2aab3b7b7b1b6b1ab2ac46Aa","doi-asserted-by":"crossref","unstructured":"Sills, G.J. (2006). The mechanisms of action of gabapentin and pregabalin. Curr. Opin. Pharmacol. 6, 108\u2013113.","DOI":"10.1016\/j.coph.2005.11.003"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_047_w2aab3b7b7b1b6b1ab2ac47Aa","doi-asserted-by":"crossref","unstructured":"Silva, M.C., Coutinho, P., Pinheiro, C.D., Neves, J.M., and Serrano, P. (1997). Hereditary ataxias and spastic paraplegias: methodological aspects of a prevalence study in Portugal. J. Clin. Epidemiol. 50, 1377\u20131384.","DOI":"10.1016\/S0895-4356(97)00202-3"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_048_w2aab3b7b7b1b6b1ab2ac48Aa","doi-asserted-by":"crossref","unstructured":"de Souza, P.V.S., de Rezende Pinto, W.B.V., de Rezende Batistella, G.N., Bortholin, T., and Oliveira, A.S.B. (2016). Hereditary spastic paraplegia: clinical and genetic hallmarks. Cerebellum (Lond.).","DOI":"10.1007\/s12311-016-0803-z"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_049_w2aab3b7b7b1b6b1ab2ac49Aa","doi-asserted-by":"crossref","unstructured":"Stevens, S.J.C., Blom, E.W., Siegelaer, I.T.J., and Smeets, E.E.J.G.L. (2015). A recurrent deletion syndrome at chromosome bands 2p11.2-2p12 flanked by segmental duplications at the breakpoints and including REEP1. Eur. J. Hum. Genet. 23, 543\u2013546.","DOI":"10.1038\/ejhg.2014.124"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_050_w2aab3b7b7b1b6b1ab2ac50Aa","doi-asserted-by":"crossref","unstructured":"Tsaousidou, M.K., Ouahchi, K., Warner, T.T., Yang, Y., Simpson, M.A., Laing, N.G., Wilkinson, P.A., Madrid, R.E., Patel, H., Hentati, F., et al. (2008). Sequence alterations within CYP7B1 implicate defective cholesterol homeostasis in motor-neuron degeneration. Am. J. Hum. Genet. 82, 510\u2013515.","DOI":"10.1016\/j.ajhg.2007.10.001"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_051_w2aab3b7b7b1b6b1ab2ac51Aa","doi-asserted-by":"crossref","unstructured":"Tzschach, A., Graul-Neumann, L.M., Konrat, K., Richter, R., Ebert, G., Ullmann, R., and Neitzel, H. (2009). Interstitial deletion 2p11.2-p12: report of a patient with mental retardation and review of the literature. Am. J. Med. Genet. A. 149A, 242\u2013245.","DOI":"10.1002\/ajmg.a.32637"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_052_w2aab3b7b7b1b6b1ab2ac52Aa","doi-asserted-by":"crossref","unstructured":"Ulengin, I., Park, J.J., and Lee, T.H. (2015). ER network formation and membrane fusion by atlastin1\/SPG3A disease variants. Mol. Biol. Cell 26, 1616\u20131628.","DOI":"10.1091\/mbc.E14-10-1447"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_053_w2aab3b7b7b1b6b1ab2ac53Aa","doi-asserted-by":"crossref","unstructured":"Vanderver, A., Tonduti, D., Auerbach, S., Schmidt, J.L., Parikh, S., Gowans, G.C., Jackson, K.E., Brock, P.L., Patterson, M., Nehrebecky, M., et al. (2012). Neurotransmitter abnormalities and response to supplementation in SPG11. Mol. Genet. Metab. 107, 229\u2013233.","DOI":"10.1016\/j.ymgme.2012.05.020"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_054_w2aab3b7b7b1b6b1ab2ac54Aa","doi-asserted-by":"crossref","unstructured":"Wijemanne, S. and Jankovic, J. (2015). Dopa-responsive dystonia\u2014clinical and genetic heterogeneity. Nat. Rev. Neurol. 11, 414\u2013424.","DOI":"10.1038\/nrneurol.2015.86"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_055_w2aab3b7b7b1b6b1ab2ac55Aa","doi-asserted-by":"crossref","unstructured":"Yal\u00e7\u0131n, B., Zhao, L., Stofanko, M., O\u2019Sullivan, N.C., Kang, Z.H., Roost, A., Thomas, M.R., Zaessinger, S., Blard, O., Patto, A.L., et al. (2017). Modeling of axonal endoplasmic reticulum network by spastic paraplegia proteins. eLife 6, pii: e23882.","DOI":"10.7554\/eLife.23882"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_056_w2aab3b7b7b1b6b1ab2ac56Aa","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Roxburgh, R., Huang, L., Parsons, J., and Davies, T.C. (2014). The effect of hydrotherapy treatment on gait characteristics of hereditary spastic paraparesis patients. Gait Posture 39, 1074\u20131079.","DOI":"10.1016\/j.gaitpost.2014.01.010"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_057_w2aab3b7b7b1b6b1ab2ac57Aa","doi-asserted-by":"crossref","unstructured":"Zhao, X., Alvarado, D., Rainier, S., Lemons, R., Hedera, P., Weber, C.H., Tukel, T., Apak, M., Heiman-Patterson, T., Ming, L., et al. (2001). Mutations in a newly identified GTPase gene cause autosomal dominant hereditary spastic paraplegia. Nat. Genet. 29, 326\u2013331.","DOI":"10.1038\/ng758"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_058_w2aab3b7b7b1b6b1ab2ac58Aa","doi-asserted-by":"crossref","unstructured":"Zhao, C., Lou, Y., Wang, Y., Wang, D., Tang, L., Gao, X., Zhang, K., Xu, W., Liu, T., and Xiao, J. (2019). A gene expression signature-based nomogram model in prediction of breast cancer bone metastases. Cancer Med. 8, 200\u2013208.","DOI":"10.1002\/cam4.1932"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_059_w2aab3b7b7b1b6b1ab2ac59Aa","doi-asserted-by":"crossref","unstructured":"Zheng, P., Chen, Q., Tian, X., Qian, N., Chai, P., Liu, B., Hu, J., Blackstone, C., Zhu, D., Teng, J., et al. (2018). DNA damage triggers tubular endoplasmic reticulum extension to promote apoptosis by facilitating ER-mitochondria signaling. Cell Res. 28, 833\u2013854.","DOI":"10.1038\/s41422-018-0065-z"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_060_w2aab3b7b7b1b6b1ab2ac60Aa","doi-asserted-by":"crossref","unstructured":"Z\u00fcchner, S., Kail, M.E., Nance, M.A., Gaskell, P.C., Svenson, I.K., Marchuk, D.A., Pericak-Vance, M.A., and Ashley-Koch, A.E. (2006a). A new locus for dominant hereditary spastic paraplegia maps to chromosome 2p12. Neurogenetics 7, 127\u2013129.","DOI":"10.1007\/s10048-006-0029-1"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_061_w2aab3b7b7b1b6b1ab2ac61Aa","doi-asserted-by":"crossref","unstructured":"Z\u00fcchner, S., Kail, M.E., Nance, M.A., Gaskell, P.C., Svenson, I.K., Marchuk, D.A., Pericak-Vance, M.A., and Ashley-Koch, A.E. (2006b). A new locus for dominant hereditary spastic paraplegia maps to chromosome 2p12. Neurogenetics 7, 127\u2013129.","DOI":"10.1007\/s10048-006-0029-1"},{"key":"2022062616291799384_j_revneuro-2019-0083_ref_062_w2aab3b7b7b1b6b1ab2ac62Aa","doi-asserted-by":"crossref","unstructured":"Z\u00fcchner, S., Wang, G., Tran-Viet, K.-N., Nance, M.A., Gaskell, P.C., Vance, J.M., Ashley-Koch, A.E., and Pericak-Vance, M.A. (2006c). Mutations in the novel mitochondrial protein REEP1 cause hereditary spastic paraplegia type 31. Am. J. Hum. Genet. 79, 365\u2013369.","DOI":"10.1086\/505361"}],"container-title":["Reviews in the Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/view\/journals\/revneuro\/31\/4\/article-p351.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/revneuro-2019-0083\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/revneuro-2019-0083\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,26]],"date-time":"2022-06-26T16:31:45Z","timestamp":1656261105000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/revneuro-2019-0083\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,8]]},"references-count":62,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,1,31]]},"published-print":{"date-parts":[[2020,5,26]]}},"alternative-id":["10.1515\/revneuro-2019-0083"],"URL":"https:\/\/doi.org\/10.1515\/revneuro-2019-0083","relation":{},"ISSN":["2191-0200","0334-1763"],"issn-type":[{"value":"2191-0200","type":"electronic"},{"value":"0334-1763","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1,8]]}}}